Barclays Maintains Underweight on BWX Technologies, Lowers Price Target to $53
Barclays maintains BWX Technologies (NYSE:BWXT) with a Underweight and lowers the price target from $57 to $53.
BWXT Names Robb LeMasters To Succeed David Black As Finance Chief
BWX Technologies Inc (NYSE:BWXT) has appointed Robb A. LeMasters as senior vice president and chief financial officer effective November 15, 2021.…
BWX Technologies Q3 Adj. EPS $0.76 Misses $0.79 Estimate, Sales $499.00M Miss $535.18M Estimate
BWX Technologies (NYSE:BWXT) reported quarterly earnings of $0.76 per share which missed the analyst consensus estimate of $0.79 by 3.8 percent. This is a 3.8 percent decrease over earnings of $0.79 per share from the
Earnings Scheduled For November 1, 2021
Companies Reporting Before The Bell
• ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter.
A Preview Of BWX Technologies’s Earnings
BWX Technologies (NYSE:BWXT) is set to give its latest quarterly earnings report on Monday, 2021-11-01. Here's what investors need to know before the announcement.
Analysts estimate that BWX Technologies will likely report an Earnings Per Share (EPS) of $0.79
BWXT, Fluor JV Secures $21B Environmental Management Contract For DOE’s Savannah River Site
U.S. Department of Energy (DOE) has selected Savannah River Mission Completion, LLC (SRMC), a joint venture led by a subsidiary…
BWX Technologies Wins Contract With Estimated Ceiling Of ~$21B Over 10-Year Ordering Period From US Dept. Of Energy For Environmental Mgmt. Operations At Savannah River Site In South Carolina
BWX Technologies, Inc. (NYSE:BWXT) today announced a contract with an estimated ceiling of approximately $21 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management
BWXT Medical, Bayer AG Ink Agreement On Actinium-225
BWX Technologies Inc’s (NYSE:BWXT) subsidiary BWXT Medical Ltd. has agreed with Bayer AG (OTC:BAYRY) to develop Actinium-225 (Ac-225) supply and further partnering opportunities…